Contineum Therapeutics, Inc. (CTNM) vs Tectonic Therapeutic, Inc. (TECX)
Contineum Therapeutics, Inc. and Tectonic Therapeutic, Inc. are both Biotechnology companies. Contineum Therapeutics, Inc. and Tectonic Therapeutic, Inc. are of similar size ($471.5M and $469.9M). Across the 9 metrics below, Contineum Therapeutics, Inc. leads on 6 and Tectonic Therapeutic, Inc. on 3.
Valuation
Profitability
| Metric | CTNM | TECX | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 0.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (28.01%) | (33.80%) | (57.72%) |
| Return on assets | (26.57%) | (32.23%) | (49.22%) |
| Return on invested capital | (1,334.41%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack